Cagrilintide Synthetic

 Product Basic Profile

Cagrilintide is full-length synthetic polypeptide composed of multiple amino acid residues. The whole production line adopts automatic solid-phase peptide synthesis equipment for complete peptide chain assembly, followed by multi-step gradient elution HPLC purification to remove truncated peptide fragments and synthesis by-products. The finished raw material is white loose lyophilized powder with stable chemical structure, low endotoxin residue and excellent water solubility. It can be fully dissolved in deionized water and pH7.2 PBS buffer to form transparent homogeneous liquid samples, only used for subsequent in vitro cell incubation and biomolecular binding interaction tests under laboratory isolated environment.

Full Product Quality Control Index System

Full Product Name: Synthetic Cagrilintide Polypeptide for In Vitro Biochemical Lab ResearchCAS Registration Number: 1415456-99-3Physical Appearance: White loose lyophilized powder, no visible foreign impurity particles, no caking or moisture absorption deliquescenceSolubility: Fully soluble in sterile ultrapure water and pH7.2 PBS aqueous solutionAll test items follow unified industry standards for lab polypeptide reagents. Each production batch is equipped with independent HPLC chromatogram and ESI-MS mass spectrum identification report to verify molecular weight and purity data batch by batch, ensuring stable and consistent performance among different production batches.

Compliant Allowed In Vitro Laboratory Research Directions

GLP-1 related endocrine cell isolated culture research: Build intestinal endocrine cell isolated culture model, study the regulatory effect of Cagrilintide polypeptide on cell secretion function and intestinal signal pathway mechanism under isolated laboratory environment.Metabolic cell basic in vitro experiment: Complete co-incubation test of intestinal epithelial cell strains and endocrine cell strains, analyze the mediation effect of Cagrilintide on cellular factor release and cell proliferation behavior.Biomolecular interaction basic academic research: Carry out co-incubation test of Cagrilintide polypeptide with nucleic acid, protein and lipid biomolecules, detect molecular binding affinity to provide complete experimental data support for biochemistry academic papers.In vitro cell inflammatory injury model construction: Establish LPS-induced cell inflammatory damage model, observe the protective effect of Cagrilintide on damaged isolated cells and explore downstream signal molecular regulation mechanism.ovel GLP-1 regulatory peptide precursor in vitro preliminary screening: Serve as standard reference polypeptide for in vitro preliminary screening of new regulatory peptide molecular templates, only limited to isolated strain and cell level testing, not used for clinical pharmaceutical preparation development or human drug research.Laboratory small trial sp

Optional Multi-specification Packaging Series

Laboratory small trial specifications: 1mg/Glass Vial, 5mg/Glass Vial, 10mg/Glass Vial, 50mg/Glass ViaAll inner packaging containers adopt low adsorption borosilicate glass and light-proof food-grade aluminum foil materials, which will not adsorb peptide powder and cause sample loss. Outer transportation packaging adopts shockproof thick foam box matched with ice packs for full-process low-temperature cold chain transportation, avoiding peptide activity decline caused by high temperature environment during transit.Long-term storage operation: Tightly seal glass vials or aluminum foil bags, store at constant temperature of -20℃ away from light and moisture, minimize repeated freeze-thaw cycles to prevent peptide chain hydrolysis and degradation